We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-11.88%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$96.1B
AUM Growth
-$15.5B
Cap. Flow
+$483M
Cap. Flow %
0.5%
Top 10 Hldgs %
15.04%
Holding
4,137
New
391
Increased
1,950
Reduced
1,291
Closed
279

Sector Composition

Rank Sector Weight
1 Financials 11.03%
2 Technology 10.74%
3 Healthcare 9.35%
4 Industrials 6.72%
5 Consumer Discretionary 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
701
APA Corp
APA
$13.2B
$24M 0.03%
915,407
+288,602
+46% +$10.6M
HES
702
PUT
DELISTED
Hess
HES
$24M 0.02%
591,900
+138,900
+31% +$7.92M
MRO
703
DELISTED
Marathon Oil Corporation
MRO
$23.9M 0.02%
1,668,338
+316,615
+23% +$5.65M
AQN icon
704
Algonquin Power & Utilities
AQN
$4.42B
$23.9M 0.02%
2,379,949
+1,899,456
+395% +$19.6M
CPT icon
705
Camden Property Trust
CPT
$11.3B
$23.9M 0.02%
271,349
-283,658
-51% -$26M
FANG icon
706
Diamondback Energy
FANG
$52.7B
$23.8M 0.02%
256,737
+110,350
+75% +$12.3M
ZBH icon
707
Zimmer Biomet
ZBH
$18.4B
$23.7M 0.02%
235,043
-41,963
-15% -$4.72M
USFD icon
708
US Foods
USFD
$24B
$23.6M 0.02%
747,387
+604,596
+423% +$18.6M
LLL
709
DELISTED
L3 Technologies, Inc.
LLL
$23.6M 0.02%
136,062
-13,675
-9% -$2.63M
DD icon
710
CALL
DuPont de Nemours
DD
$19.2B
$23.5M 0.02%
173,748
+86,203
+98% +$12.4M
LH icon
711
Labcorp
LH
$25.9B
$23.5M 0.02%
216,473
-1,963
-0.9% -$263K
TEVA icon
712
Teva Pharmaceuticals
TEVA
$41.2B
$23.4M 0.02%
1,514,856
-826,456
-35% -$16.9M
FLGE
713
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
$23.4M 0.02%
123,332
-25,487
-17% -$6.1M
TTM
714
DELISTED
Tata Motors Limited
TTM
$23.3M 0.02%
1,915,190
+460,223
+32% +$5.75M
NBIS
715
Nebius Group N.V.
NBIS
$47.7B
$23.2M 0.02%
848,898
-41,097
-5% -$1.21M
JOYY
716
JOYY Inc
JOYY
$3.75B
$23.2M 0.02%
387,631
+149,779
+63% +$9.76M
OMCL icon
717
Omnicell
OMCL
$1.68B
$23.2M 0.02%
378,838
+69,342
+22% +$4.69M
NVRO
718
DELISTED
NEVRO CORP.
NVRO
$23.2M 0.02%
595,759
+52,692
+10% +$2.34M
KEY icon
719
KeyCorp
KEY
$24.4B
$23.1M 0.02%
1,562,940
+117,056
+8% +$2.06M
CMD
720
DELISTED
Cantel Medical Corporation
CMD
$23.1M 0.02%
310,184
-8,786
-3% -$725K
EMB icon
721
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$23.1M 0.02%
222,206
+30,543
+16% +$3.19M
AMAT icon
722
CALL
Applied Materials
AMAT
$428B
$23M 0.02%
703,200
+26,800
+4% +$919K
LUMN icon
723
Lumen
LUMN
$6.44B
$23M 0.02%
1,519,359
+241,724
+19% +$4.61M
TAK icon
724
Takeda Pharmaceutical
TAK
$55.7B
$23M 0.02%
+1,367,880
New +$23.1M
DD icon
725
PUT
DuPont de Nemours
DD
$19.2B
$23M 0.02%
169,838
+155,622
+1,095% +$22.3M

Similar funds

Credit Suisse's Q4 2018 Portfolio in Review

As of Q4 2018, Credit Suisse held 4,137 positions worth $96.1B, down 14% from $112B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse's Q4 2018 filing shows 391 new, 1,950 increased, 1,291 reduced and 279 closed positions. Its largest new stake was Linde: 1,955,783 shares worth $305M. The largest sale was UnitedHealth, an estimated $1.57B.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

  • Credit Suisse's largest Q4 2018 buy was Linde: 1,955,783 shares worth $305M.
  • Credit Suisse added most to VanEck Gold Miners ETF in Q4 2018, an estimated $385M increase.
  • Credit Suisse's biggest Q4 2018 reduction was UnitedHealth, cutting an estimated $1.57B.
  • Credit Suisse fully exited Grifois in Q4 2018, selling an estimated $190M.
  • Credit Suisse's ten largest holdings make up 15% of its $96.1B portfolio in Q4 2018.
  • Credit Suisse opened 391 new positions and closed 279 in Q4 2018.
  • Credit Suisse's portfolio value fell 14% quarter-over-quarter to $96.1B.

Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.